Moderna Plans to Spend $500 Million on Vaccine Plant in Africa

Facility could make Covid, other shots based on messenger RNA
Biotech company has faced pressure to make shots in Africa

A box of the Moderna Covid-19 vaccine vials at a drive-thru vaccination site at the Meigs County fairgrounds in Pomeroy, Ohio, U.S., on Thursday, March 18, 2021. President Joe Biden is poised to meet his goal of delivering 100 million Covid-19 vaccine shots in his first 100 days in office as soon as Thursday, reaching the milestone more than a month ahead of time.Photographer: Stephen Zenner/Bloomberg

Have a confidential tip for our reporters? Get in Touch

Before it’s here, it’s on the Bloomberg Terminal

LEARN MORE

By Robert Langreth

October 7, 2021 at 2:00 AM EDT

This article is for subscribers only.

Sign up to our Next Africa newsletter and follow Bloomberg Africa on Twitter

Moderna Inc. said it would spend as much as $500 million to build a factory in Africa that could produce half a billion messenger RNA vaccine doses a year.

Have a confidential tip for our reporters? Get in Touch

Before it’s here, it’s on the Bloomberg Terminal

LEARN MORE